Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Emerge Weight Loss vs Noom Med

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

Emerge Weight Loss

Best for patients committed to tirzepatide as their drug of choice
★★★3.8

Starting at $299/mo

CompoundedTirzepatideTelehealthPhysician supervised
Visit Emerge Weight Loss
8.6

Noom Med

Best for psychology + medication combo
★★★★4.3

Starting at $99/mo

GLP-1 IntegrationCBT CoachingDietitian
Visit Noom Med

Side-by-Side Comparison

FeatureEmerge Weight LossNoom Med
Overall Score7.6/108.6/10
Starting Price$299/mo$99/mo
Editorial Rating3.8 ★ /54.3 ★ /5
Features4 features3 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Emerge Weight Loss

Pros

  • Tirzepatide-focused (largest effect-size compounded GLP-1)
  • Wide dose range available
  • Physician-supervised telemedicine model

Cons

  • No semaglutide option — limits flexibility if tirzepatide tolerability is poor
  • Less brand recognition than Henry Meds, Mochi, or SkinnyRx

Noom Med

Pros

  • Combines GLP-1 medication with CBT behavior change
  • Dedicated dietitian included in every plan
  • Highest support score in fitness app category
  • Integrated care team for medication and coaching
  • Noom's proven behavioral curriculum

Cons

  • Available in only 40 states — excludes AK, HI, ID, MT, NM, SD, VT, WV, WY, ND
  • More expensive than app-only alternatives
  • Requires commitment to both medication and coaching program

Our Verdict

Winner: Noom MedScore: 8.6/10

Noom Med edges out Emerge Weight Loss with a higher overall score of 8.6/10 and is particularly strong for psychology + medication combo. Emerge Weight Loss remains a solid alternative, especially if you're looking for patients committed to tirzepatide as their drug of choice.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.